Drug Profile
Kringle 5 - Abbott Laboratories
Alternative Names: Kringle-5 - AbbottLatest Information Update: 01 Feb 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Antineoplastics
- Mechanism of Action Angiogenesis inhibitors; Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 19 Aug 2005 Preclinical trials in Cancer in USA (unspecified route)